このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Krishna Institute of Medical Sciences マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Abhinay Bollineni
最高経営責任者
₹22.0m
報酬総額
| CEO給与比率 | 77.3% |
| CEO在任期間 | 5.2yrs |
| CEOの所有権 | 0.07% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 2.3yrs |
経営陣の近況
Recent updates
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹22m | ₹17m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹3b |
| Mar 31 2023 | ₹20m | ₹15m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹3b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹12m | ₹12m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹9m | ₹9m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹8m | ₹8m | ₹1b |
| Mar 31 2019 | ₹5m | ₹5m | -₹477m |
報酬と市場: Abhinayの 総報酬 ($USD 262.33K ) は、 Indian市場 ($USD 473.89K ) の同様の規模の企業の平均を下回っています。
報酬と収益: Abhinayの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Abhinay Bollineni (36 yo)
5.2yrs
在職期間
₹22,000,000
報酬
Dr. Abhinay Bollineni serves as Chief Executive Officer of Krishna Institute of Medical Sciences Limited since July 3, 2019 and has been its Executive Director since January 18, 2019. He holds a bachelor’s...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | no data | ₹38.67m | 32.25% ₹ 71.8b | |
| CEO & Executive Director | 5.7yrs | ₹22.00m | 0.069% ₹ 153.5m | |
| Director of Operations & Wholetime Director | no data | ₹5.80m | データなし | |
| Independent Director | no data | ₹3.52m | データなし | |
| Additional Non-Executive & Independent Director | 2.3yrs | ₹1.06m | データなし | |
| Independent Director | no data | ₹1.06m | データなし | |
| Additional Non-Executive Non-Independent Director | less than a year | データなし | 0.010% ₹ 22.6m | |
| Independent Director | no data | ₹1.06m | データなし |
2.3yrs
平均在職期間
70yo
平均年齢
経験豊富なボード: KIMSの 取締役会 は 経験豊富 ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。